Scholars Central

Conference abstractPublished 23 Nov 2012

Understanding facility validation for GMP compliance

Authors: J. Ramniwas

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In the past decade, many far-reaching changes have taken place in the application of cGMP regulations relating to the pharmaceutical industry. Continuous quality improvement thus is ingrained in the cGMP concept. The design, construction, commissioning, and validation of pharmaceutical facilities play very important role in the risk mitigation of product Quality and Safety. Among the six GMP systems of US FDA requirements for facility system are particularly important for pharmaceutical companies to understand and implement this GMP requirement therefore constructing new facilities and reconstructing the existing ones both require the compliance with the GMP. Facility qualification (a part of validation that proves and documents that equipment or ancillary systems are properly installed, work correctly, and actually lead to the expected results), and validation (establishing documented evidence that provides a high degree of assurance that the manufacturing processes, including buildings, systems, and equipment consistently produce the desired results according to predetermined specifications and quality attributes) activities will establish and provide documentary evidence that the facility suitable for the intended use for manufacturing, testing, storage meeting GMP requirements.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Pharmaceutical Regulatory Affairs: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Regulatory Affairs: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “J. Ramniwas”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels